Athersys Therapeutics (ATHX) - Time to Buy When No One Else is
ATHX has been trailing off lately. Yet the CEO bought shares recently as the release of the results of an important test of its Multistem product is imminent. No guarantees but could be good. For more read this.
As always...do your own DD.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.